No chapters are available for this episode.
Ep. 02
Please Subscribe, Share and Like.
Source Studies: https://longevity.pink/featured-studies/ AI Fact Check: https://www.perplexity.ai/search/please-can-you-fact-check-this-yMlCloYSTF6e.OIKd4UnAA
In this captivating episode of The Longevity Pink Podcast, host Jamie Briggs takes you on a journey through the latest breakthroughs in the quest to extend human life. Discover how cutting-edge technologies like CRISPR and the OSK genes are revolutionizing our understanding of aging and longevity.
Episode Highlights:
CRISPR/dCas9 Revolution: Explore the groundbreaking work of Nobel laureates Dr. Jennifer Doudna and Dr. Emmanuelle Charpentier, and learn how CRISPR technology is transforming gene editing and aging research.
OSK Genes and Aging Reversal: Delve into the potential of OSK genes to reset our cellular clocks and rejuvenate cells, with insights from pioneering studies and the work of Dr. David Sinclair.
Ancient Discoveries: Uncover the fascinating history of Rapamycin, a compound discovered on Easter Island, and its potential to extend lifespan.
Ethical Considerations: Engage in a thoughtful discussion on the ethical implications of life extension technologies, from the risks of DIY gene editing to the philosophical questions of identity and ethics.
Join us as we navigate the exciting frontier of aging reversal, challenge conventional wisdom, and envision a future where longevity science enriches lives globally. Whether you’re a curious newcomer or a seasoned enthusiast, this episode promises to ignite your imagination and inspire thoughtful conversation.
Stay curious, stay young at heart, and let’s continue this exciting exploration together!
Connect with Us:
Homepage: https://longevity.pink Twitter: x.com/@LongevityPink Patreon: https://patreon.com/LongevityPinkPodcast Email: hello@longevity.pink SMS: +447879970193 (no WhatsApp) License Information:
The podcast is open, and you can remix, republish, and reuse the audio content under the NON-AI CC0 1.0 Universal license. The script is open source and is published under the Creative Commons CC0, allowing most uses similar to the public domain.